Cancer kills more than 26,000 people every day. That figure, released today in the WHO Global Status Report on Cancer 2026, sits at the center of a stark warning from the World Health Organization: without urgent action, the disease is on course to become far worse.
With an estimated 20.6 million new cases and close to 10 million deaths annually, cancer remains the second leading cause of death globally, after cardiovascular disease. Without urgent action, annual cancer cases are projected to rise to nearly 35 million by 2050.
The report, developed jointly with the International Agency for Research on Cancer (IARC), does not just document numbers. It documents a gap, between the countries that can treat cancer and those that cannot.
While 87% of women with breast cancer survive five years after diagnosis in high-income countries, only about 42% do so in low-income countries. Fewer than one in three countries currently include cancer care in their universal health coverage packages.
“Cancer is a deeply personal disease that touches nearly all of us,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “The inequities documented in this report are not inevitable; they are the consequence of choices, and they can be reversed through stronger and unified action.”
The burden is uneven — and widening
In 2024, Asia accounted for the largest share of global cancer burden, with more than half of all cases (50.7%) and deaths (56.5%). Europe carried a disproportionately high burden, contributing 21% of global cases and 20% of deaths despite having only about 9% of the world’s population.
Lung cancer remains the leading cause of cancer death globally. Lung, prostate and colorectal cancers are among the most common in men, while breast, lung and colorectal cancers account for a substantial share of the burden among women.
Nearly four in ten cancer cases globally are linked to preventable risk factors, particularly infections such as human papillomavirus (HPV), hepatitis B and C, and helicobacter pylori, alcohol, tobacco use, high body mass index and insufficient physical activity.
Progress exists, but it’s too slow
The report acknowledges genuine gains. Tobacco use has declined by 27% since 2010, contributing to reductions in lung cancer cases and deaths in some regions. Political commitment has strengthened, with 82% of countries now having national cancer control plans, up from 50% in 2010. Registered clinical trials have increased at an annual rate of 7.3% between 2005 and 2021.
But access to treatment tells a different story. Availability of the top 20 priority cancer medicines ranges from just 9% to 54% in low- and lower-middle-income countries, compared with 68% to 94% in high-income countries.
“The cancer profile is evolving, increasingly driven by rising rates of obesity, physical inactivity, unhealthy diets, and air pollution,” said Dr Elisabete Weiderpass, Director of IARC. “Cancer prevention must remain a political priority.”
The human cost beyond survival rates
WHO’s first-ever survey of people affected by cancer found that at least 45% experience financial hardship, more than half report mental health challenges, and nearly all caregivers report strain including unpaid services and social isolation.
These are not side effects of cancer. They are part of the disease’s impact, and the report argues they have been systematically ignored in how countries plan cancer care.
“Cancer is not just a medical diagnosis, it profoundly, indefinitely affects every aspect of a person’s life, and their family’s as well,” said Clarissa Schilstra, a childhood cancer survivor and lead of WHO’s survey. “We urge policymakers to meaningfully engage with people affected by cancer.”
What the report calls for
The report outlines three strategic shifts: better capabilities, integrating cancer control into universal health coverage; better protections, placing people with lived experience at the center of cancer systems; and better value, aligning research and innovation with public health needs to ensure equitable access.
The message from WHO is direct: the tools to reduce the cancer burden exist. The gap between countries that use them and countries that cannot is a policy failure, not an inevitability.
The choices made now, the report states, will determine the cancer burden the next generation inherits.
